Presentation is loading. Please wait.

Presentation is loading. Please wait.

The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation  Rona Spector, MD, Yifan Zheng, MD, Beow.

Published byἩσίοδος Βλαβιανός Modified over 6 years ago

Similar presentations

Presentation on theme: "The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation  Rona Spector, MD, Yifan Zheng, MD, Beow."— Presentation transcript:

1 The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation  Rona Spector, MD, Yifan Zheng, MD, Beow Y. Yeap, ScD, Jon O. Wee, MD, Abraham Lebenthal, MD, Scott J. Swanson, MD, David E. Marchosky, MD, Peter C. Enzinger, MD, Harvey J. Mamon, MD, Antoon Lerut, MD, PhD, Robert Odze, MD, Amitabh Srivastava, MD, Agoston T. Agoston, MD, Mingkhwan Tippayawang, MD, Raphael Bueno, MD  Seminars in Thoracic and Cardiovascular Surgery  Volume 27, Issue 2, Pages (June 2015) DOI: /j.semtcvs Copyright © 2015 The Authors Terms and Conditions

2 Figure 1 (A) Overall survival for 107 patients with cancer of pathologic stages 0-2. (central picture). (B) Overall survival for 69 patients with cancer of pathologic stages 0-2 (neoadjuvant group). Seminars in Thoracic and Cardiovascular Surgery  , DOI: ( /j.semtcvs ) Copyright © 2015 The Authors Terms and Conditions

3 Figure 2 (A) Overall survival for patients with early-stage cancer—by pathologic stage in neoadjuvant group. (B) Overall survival for patients with early-stage cancer in surgery-only group—by pathological stage. Seminars in Thoracic and Cardiovascular Surgery  , DOI: ( /j.semtcvs ) Copyright © 2015 The Authors Terms and Conditions

4 Overall survival for 107 patients with cancer of pathologic stage 0–2.
Seminars in Thoracic and Cardiovascular Surgery  , DOI: ( /j.semtcvs ) Copyright © 2015 The Authors Terms and Conditions

Download ppt "The 3-Hole Minimally Invasive Esophagectomy: A Safe Procedure Following Neoadjuvant Chemotherapy and Radiation  Rona Spector, MD, Yifan Zheng, MD, Beow."

Similar presentations

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E

Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer  Yoichi.

Results of Neoadjuvant Chemoradiotherapy With Docetaxel and 5-Fluorouracil Followed by Esophagectomy to Treat Locally Advanced Esophageal Cancer  Yoichi.
Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L
Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non–small cell lung cancer  Kamran.

Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤2 cm) non–small cell lung cancer  Kamran.
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 

One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection  Morihito Okada,
Remote Ischemic Preconditioning in High-risk Cardiovascular Surgery Patients: A Randomized-controlled Trial  Nicole S. Coverdale, PhD, Andrew Hamilton,

Remote Ischemic Preconditioning in High-risk Cardiovascular Surgery Patients: A Randomized-controlled Trial  Nicole S. Coverdale, PhD, Andrew Hamilton,
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Ultrasound, endoscopy, and the recurrent nerve

Ultrasound, endoscopy, and the recurrent nerve
Philip A. Linden, MD, Richard J. Gilbert, MD, Beow Y

Philip A. Linden, MD, Richard J. Gilbert, MD, Beow Y
Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T

Robert E. Merritt, MD, Richard I. Whyte, MD, Nicole T
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life  Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,

Esophageal Resection for Cancer of the Esophagus: Long-Term Function and Quality of Life  Allison J McLarty, MD, Claude Deschamps, MD, Victor F Trastek,
Early Outcomes with Rapid-deployment vs Stented Biological Valves: A Propensity- match Analysis  Anthony Nguyen, MD, MSc, Louis-Mathieu Stevens, MD, PhD,

Early Outcomes with Rapid-deployment vs Stented Biological Valves: A Propensity- match Analysis  Anthony Nguyen, MD, MSc, Louis-Mathieu Stevens, MD, PhD,
Minimally invasive Ivor Lewis esophagectomy

Minimally invasive Ivor Lewis esophagectomy

Similar presentations

Ads by Google